Navigation Links
Smart Balance Announces Conversion of Convertible Preferred Stock
Date:1/3/2008

Improves capital structure; approximately 19.5 million common shares to be

issued

PARAMUS, N.J., Jan. 3 /PRNewswire-FirstCall/ -- Smart Balance Inc. (Nasdaq: SMBL) announced today it is forcing the conversion of its Series A Convertible Preferred Stock. At 5:00 p.m., Eastern Time, today, each preferred share will be automatically converted into approximately 1.268 shares of common stock. All of the issued and outstanding shares of Series A Convertible Preferred will cease to exist.

"We have reached another milestone in the evolution of our capital structure," commented Robert S. Gluck, vice chairman and CFO of Smart Balance Inc. "The conversion improves our debt/equity ratio and should help toward raising our credit ratings. We will continue to work on improving our financial position to facilitate funding Smart Balance's growth opportunities."

The Company is exercising its right to force the conversion of its Series A Convertible Preferred Stock based on meeting the conditions in the Company's Restated Certificate of Incorporation governing the terms of the preferred shares. One condition was that the last sales price of the Company's common stock equals or exceeds $11.50 per share on 20 trading days within a 30 day trading period ending on the third business day prior to the date on which notice of conversion is given. This condition was met on the 30 day trading period ended December 28, 2007. Another condition required the redemption of the Company's outstanding public warrants, which was met on December 3, 2007.

A total of approximately 19.5 million common shares will be issued upon the conversion, which includes the pay-out of in-kind dividends. With this issue, the total
'/>"/>

SOURCE Smart Balance Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. New Smart Technology Makes Patient Data Collection Easier, More Efficient
2. New Survey Shows Americans are Still Concerned About Food Safety, Yet Still Not Smart About What They Like to Eat
3. Delta Dental of Illinois Introduces Smile Smart For Your Health
4. Toddler Study Proves Humans Outsmart Apes
5. SMART Association Becomes Healthcare Council Member of Smart Card Alliance
6. Smart insulin nanostructures pass feasibility test, UT study reports
7. New Oral-B(R) Triumph(TM) With SmartGuide(TM) is the First Power Toothbrush With a Wireless Display
8. Pasta Gets Smarter - and Healthier
9. Healthy Living Made Easy with New Diabetes Foodsmart e-Newsletter
10. Oridion Introduces New Smart Capnography System for Improved Patient Safety
11. SafeSmart, Inc. Presents SafetyTies to Sixth Annual MedAssets Technology Forum

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)... , The European Association of Urology (EAU) and ...he fight against prostate cancer, have entered int...-term commitment to increase and improve,patient ...eases., Professor Per-Anders Abrahamsson, Secret...U affiliated partnership, Europa Uomo will gain ac...
(Date:11/30/2009)... CHICAGONovember 30, 2009A pet owner knows the en... especially in troubled times. Most pets are consi...eable companions. A growing body of research now d...ld development, elderly care, mental illness, phys...ry, and the rehabilitation of incarcerated youth a...
(Date:11/30/2009)... The University of Navarra Hospital has launched ... efficacy of an immunotherapy treatment. This appr...ines produced from healthy and tumour cells from t...lioblastomas, one of the most aggressive and frequ...ered to participating patients combined with the s...
(Date:11/30/2009)... Author of "My Two-Y...r raising children who love to eat everything. , ...-- Do you have a picky eater in your house? Do yo...altime? Three new short online videos – one...ners, and the third on answers for real-life paren...
(Date:11/30/2009)...Like a pothole that worsens over time, so do knees...ONDAY, Nov. 30 (HealthDay News) -- If you,re a mid...tball court or hockey rink, take note: A new study...ost the risk of internal knee damage that could le...e injuries occurred in middle-age people who showe...
Breaking Medicine News(10 mins):Health News:The therapeutic benefits of the human-animal bond 2Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 2Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 3Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 4Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 5Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 6Health News:New Videos Help Parents of Picky Eaters 2Health News:New Videos Help Parents of Picky Eaters 3Health News:Lots of Exercise in Midlife May Lead to Osteoarthritis 2Health News:Lots of Exercise in Midlife May Lead to Osteoarthritis 3
...mirror LLC, a Philadelphia-based company offering ...DNA testing, is announcing the launch of their inn... affordable, easy-to-use product, with its user-fr...l HIV disease progression. HIVmirror(TM) i...
...earth endures, seedtime and harvest, cold and heat...e." - (Genesis 8:22, The Bible ). ...metime now. Needless to say, we, the people, of th...g the environmental crisis began way back in the t...
...enter for Consumer Freedom (CCF) welcomed a new st...tric & Adolescent Medicine, which will contribute ... the supposed link between television food adverti...that "children do not currently see more food ads ...
...udies have already revealed that stress boosts the...ers disease, a new study on mice has now shown th...ress-induced increases. The study, reported...first studies to elaborate the basic biomolecular ...
...ted wheat germ extract inhibits estrogen positive ...than the world's best selling cancer drug, Tamoxi...kend at the 2007 meeting of the American Society o...cal trials. In the current study, Andras Telekes, ...
...ound that tumor cell activity in women differs acc...east cancer in younger women. Breast canc... to treatment in women under 50 as compared to old...searchers led by Carey Anders at the Duke Institut...
Other Medicine News:Health News:HIVmirror, LLC Launching Breakthrough Genetic Product for HIV Positive Consumer 2Health News:World Environment Day (International Polar Year) 2Health News:World Environment Day (International Polar Year) 3Health News:World Environment Day (International Polar Year) 4Health News:New Studies: Commercials Aren't Making Kids Fat 2Health News:Stress Protein Inactivation Cuts Alzheimer's Peptide in Mice 2Health News:Wheat Germ Extract Inhibits Breast Cancer in Study 2
(Date:11/30/2009)... , , INDIANAPOLIS, Nov. 30 /PRNew...tration (FDA) has approved Cymbalta® (duloxet...zed anxiety disorder (GAD) in adults, Eli Lilly an...ince generalized anxiety disorder can be a chronic...atients find a treatment option that is effective ...
(Date:11/30/2009)... , , THOUSAND OAKS, Calif., Nov. 30 /PR... today announced that it will present updated long...omiplostim) in adult chronic immune (idiopathic) t... will present the first Nplate study in a pediatri...tic syndromes (MDS) at the 2009 American Society o...
(Date:11/29/2009)... , , CHICAGO, Nov. 30 Rad...is from a remote location with the use of a handhe...ftware, according to a study presented today at th...rth America (RSNA). ,, "The goal is to improve...ell as to improve communications among different c...
Breaking Medicine Technology:FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder 2FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder 3FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder 4FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder 5Amgen Highlights Data to be Presented at ASH 2Amgen Highlights Data to be Presented at ASH 3Amgen Highlights Data to be Presented at ASH 4Amgen Highlights Data to be Presented at ASH 5Amgen Highlights Data to be Presented at ASH 6Amgen Highlights Data to be Presented at ASH 7Amgen Highlights Data to be Presented at ASH 8Amgen Highlights Data to be Presented at ASH 9Amgen Highlights Data to be Presented at ASH 10Amgen Highlights Data to be Presented at ASH 11Smart Phones Allow Quick Diagnosis of Acute Appendicitis 2Smart Phones Allow Quick Diagnosis of Acute Appendicitis 3LG Electronics Introduces New Flat Panel HDTVs Designed Specifically for Long Term Care Facilities 53486 1LG Electronics Introduces New Flat Panel HDTVs Designed Specifically for Long Term Care Facilities 53486 2LG Electronics Introduces New Flat Panel HDTVs Designed Specifically for Long Term Care Facilities 53486 3LG Electronics Introduces New Flat Panel HDTVs Designed Specifically for Long Term Care Facilities 53486 4SENOMYX AND FIRMENICH TO COLLABORATE ON DISCOVERY DEVELOPMENT AND WORLDWIDE COMMERCIALIZATION OF NOVEL SWEET ENHANCERS 13331 1SENOMYX AND FIRMENICH TO COLLABORATE ON DISCOVERY DEVELOPMENT AND WORLDWIDE COMMERCIALIZATION OF NOVEL SWEET ENHANCERS 13331 2SENOMYX AND FIRMENICH TO COLLABORATE ON DISCOVERY DEVELOPMENT AND WORLDWIDE COMMERCIALIZATION OF NOVEL SWEET ENHANCERS 13331 3SENOMYX AND FIRMENICH TO COLLABORATE ON DISCOVERY DEVELOPMENT AND WORLDWIDE COMMERCIALIZATION OF NOVEL SWEET ENHANCERS 13331 4SENOMYX AND FIRMENICH TO COLLABORATE ON DISCOVERY DEVELOPMENT AND WORLDWIDE COMMERCIALIZATION OF NOVEL SWEET ENHANCERS 13331 5PDL BioPharma Elects Barry Selick to Its Board of Directors 53479 1PDL BioPharma Elects Barry Selick to Its Board of Directors 53479 2
..., Fla. , May 29 GlaxoSmithKline [NYSE: GSK] and ...ted States Food and Drug Administration,s (FDA) On...o three that the ARZERRA(TM) (ofatumumab) data are... patients with chronic lymphocytic leukemia (CLL) ...mtuzumab. Ofatumumab is an investigational treatme...
...VILLE, Pa., May 29 Wyeth Pharmaceuticals, a divis...minary data from two ongoing studies, one evaluati...umab (Herceptin(R), Roche) in HER-2 positive (ErbB...nvestigating neratinib safety and efficacy when gi...b) in patients with HER-2 dependent solid tumors. ...
Other Medicine Technology:FDA Advisory Panel Makes Favorable Recommendation for GlaxoSmithKline and Genmab's ARZERRA(TM) (ofatumumab) 2FDA Advisory Panel Makes Favorable Recommendation for GlaxoSmithKline and Genmab's ARZERRA(TM) (ofatumumab) 3FDA Advisory Panel Makes Favorable Recommendation for GlaxoSmithKline and Genmab's ARZERRA(TM) (ofatumumab) 4FDA Advisory Panel Makes Favorable Recommendation for GlaxoSmithKline and Genmab's ARZERRA(TM) (ofatumumab) 5New Preliminary Data from Two Studies Show Clinical Activity of Neratinib in Combination with Trastuzumab and in Combination with Paclitaxel in Advanced HER-2 Positive Breast Cancer 2New Preliminary Data from Two Studies Show Clinical Activity of Neratinib in Combination with Trastuzumab and in Combination with Paclitaxel in Advanced HER-2 Positive Breast Cancer 3New Preliminary Data from Two Studies Show Clinical Activity of Neratinib in Combination with Trastuzumab and in Combination with Paclitaxel in Advanced HER-2 Positive Breast Cancer 4New Preliminary Data from Two Studies Show Clinical Activity of Neratinib in Combination with Trastuzumab and in Combination with Paclitaxel in Advanced HER-2 Positive Breast Cancer 5
7121B Sony Medical Monitor
...ompletely new and revolutionary lens system. The u... size without distortion. The 115 field of view su...tion of the telescope. Beyond that a new quick loc... is introduced. It is the combination of outstandi...
...e the surgeon with an optimal work area and reduce...t and retinal surgery. Perfect Pupil Injectable is...pils which allows expansion of the pupil to 8mm co...gery, and allows the pupil to return to its normal...
Defiant 95% Bag Filter
Medicine Products: